Evidence map›Paper›PMID 42665654›Full record

ArticleJournal of human genetics2026

Cross-biobank comparison of ASCVD heritability and genetic correlation.

Hari B Acharya, Samuel S Gidding, Matthew T Oetjens, Alexander S F Berry

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of human genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hari B AcharyaDepartment of Developmental Medicine, Geisinger, Lewisburg, PA, USA.
Samuel S GiddingDepartment of Genomic Health, Geisinger, Danville, PA, USA.
Matthew T OetjensDepartment of Developmental Medicine, Geisinger, Lewisburg, PA, USA. mtoetjens@geisinger.edu.
Alexander S F BerryDepartment of Developmental Medicine, Geisinger, Lewisburg, PA, USA. asberry@geisinger.edu.ORCID http://orcid.org/0000-0003-0353-5521

Funding

Improving Risk Stratification in Familial Hypercholesterolemia (RISK-FH)R01HL159182 · NHLBI · GEISINGER CLINIC · PI Matthew Oetjens · 2022 to 2026
$3.7M
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) R01HL159182
6 · The paper itself

Abstract

Estimates of SNP-based heritability for atherosclerotic cardiovascular disease (ASCVD) vary widely across populations, complicating interpretation of genetic architecture. We compared SNP-based heritability and cross-cohort genetic correlation for ASCVD and its nested subphenotypes, coronary events (CE) and myocardial infarction (MI), across Geisinger's MyCode, the UK Biobank, and the NIH's All of Us using GWAS summary statistics and LD score regression. Heritability estimates differed significantly across cohorts, with consistently higher values in the UK Biobank and higher heritability for more narrowly defined phenotypes (MI) relative to broader ASCVD definitions. In contrast, genetic correlations between cohorts were uniformly high for all phenotypes, with confidence intervals spanning 1.0. These results suggest substantial sharing of common variant genetic effects across biobanks and indicate that cross-cohort differences in SNP-based heritability may primarily reflect differences in ASCVD ascertainment and phenotype capture rather than underlying genetic architecture.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.